Tamil Nadu CM MK Stalin refuted claims made by the opposition and said that attempts to politicise the issue for short-term gains would not succeed. He emphasised that the state government is ...
MK-6837 is under clinical development by Merck and currently in Phase I for Solid Tumor. According to GlobalData, Phase I drugs for Solid Tumor have a 69% phase transition success rate (PTSR) ...
MK-6194 is under clinical development by Merck and currently in Phase II for Ulcerative Colitis. According to GlobalData, Phase II drugs for Ulcerative Colitis have a 45% phase transition success rate ...